Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Coagulation Defects Promote False Lumen Patency in Type A Aortic Dissection.

Created on 11 Sep 2026

Authors

Yattheesh Thanalingam, Daniel Fudulu, Kelly Byrne, Francesco Pirone, Nishith N Patel

Published in

Heart, lung & circulation. Sep 10, 2026. Epub Sep 10, 2026.

Abstract

Acute type A aortic dissection (TAAD) is associated with high mortality and morbidity. False lumen (FL) patency is associated with malperfusion, aortic expansion, reoperation and reduced survival. Our aim was to determine if coagulation defects predict the fate of the FL.
We conducted a single-centre, retrospective, case-controlled study of patients with TAAD. Patient demographics, preoperative characteristics, operative details, postoperative complications, and follow-up computed tomography scans at 1 year were compared between patients who presented with patent FL and thrombosed FL. Coagulopathy was evaluated using standard laboratory tests and thromboelastography on admission, postoperatively, and at discharge. The primary outcome was long-term survival.
Of 123 eligible patients with TAAD, 67% (n=79) had patent FL and 33% (n=38) had thrombosed FL. Patent FL was associated with higher in-hospital (38.0 % vs 5.3% p<0.05) and mid-term mortality (93.0% vs 7.0%, p<0.05), postoperative dialysis (5.1% vs 0, p=0.04) and gastrointestinal ischaemia (17.7% vs 5.3%, p<0.05) compared to the thrombosed FL group. Survival analysis included a maximum follow-up of 8.61 years and demonstrated reduced survival in patients with a patent FL (hazard ratio [HR] 10.2, 95% confidence interval [CI] 3.00-34.6, p<0.001). Multivariable logistic regression analysis identified preoperative activated partial thromboplastin time (APTT), postoperative day 1 APTT, R value and alpha angle as independent predictors of patent FL.
Patients with a patent FL have a higher risk of mid- and long-term mortality and postoperative morbidity. Abnormalities in coagulation tests, particularly of the intrinsic pathway, are associated with FL patency. The coagulation cascade represents a novel therapeutic target to promote FL thrombosis.

PMID:
42722539
Bibliographic data and abstract were imported from PubMed on 11 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement